Madopar 125/Madopar 250/Madopar Dispersible 125/Madopar HBS 125

Madopar 125/Madopar 250/Madopar Dispersible 125/Madopar HBS 125 Indications/Uses

benserazide + levodopa

Manufacturer:

Roche

Marketer:

DKSH
Full Prescribing Info
Indications/Uses
Parkinson's disease: Madopar is indicated for the treatment of Parkinson's disease with the exception of drug-induced Parkinsonism.
Madopar dispersible is a formulation which is suitable for patients with dysphagia (difficulties in swallowing) or who require a formulation with a more rapid onset of action, e.g. patients suffering from early morning and afternoon akinesia, or who exhibit 'delayed on' or 'wearing off' phenomenon.
Madopar HBS is indicated for patients presenting with all types of fluctuations (i.e. 'peak dose dyskinesia' and 'end of dose deterioration' - such as nocturnal immobility).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in